Home / Health / ADHD Meds & Psychosis: What Aussies Need to Know
ADHD Meds & Psychosis: What Aussies Need to Know
16 Nov
Summary
- Psychosis risk from ADHD stimulants is low, comparable to other common medications.
- Stimulant use for ADHD linked to reduced accidents and suicidal thoughts.
- Proper assessment and prescription adherence minimize potential psychosis risks.

Recent reports in Australia highlight concerns about psychosis linked to stimulant medications prescribed for ADHD. Psychosis, a symptom involving a disconnect from reality, can be a serious health issue. While psychosis can be a symptom of mental illnesses like schizophrenia, some individuals experience a single episode and recover fully.
Stimulants, such as methylphenidate and amphetamines, are common ADHD treatments in Australia, boosting dopamine and noradrenaline for improved focus. Prescriptions have risen significantly, with nearly 600,000 Australians using these medications. Evidence strongly supports their effectiveness in reducing ADHD symptoms and associated harms like accidents and substance misuse.
The risk of psychosis from prescribed stimulants is low, estimated at 0.2-3%, and potentially lower than that of other widely used medications. Research indicates that even when psychosis occurs, it doesn't always lead to a lasting disorder. However, the risk escalates with non-therapeutic or illicit stimulant use.
Some studies show no link between stimulants and psychosis, and it's possible individuals with ADHD have a higher inherent risk. Amphetamines may carry a slightly higher risk than methylphenidate. Crucially, individuals should undergo thorough assessments for ADHD, take medications strictly as prescribed, and maintain regular contact with healthcare professionals to monitor for any warning signs.